XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 37 filers reported holding XERIS PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $554,000 | -70.1% | 226,239 | -50.2% | 0.00% | -100.0% |
| Q2 2021 | $1,850,000 | +139.3% | 454,537 | +165.2% | 0.00% | 0.0% |
| Q1 2021 | $773,000 | +202.0% | 171,395 | +296.6% | 0.00% | – |
| Q3 2020 | $256,000 | -80.9% | 43,220 | -91.4% | 0.00% | -100.0% |
| Q2 2020 | $1,341,000 | +10.9% | 504,243 | +194.1% | 0.00% | 0.0% |
| Q4 2019 | $1,209,000 | +31.7% | 171,460 | +83.4% | 0.00% | +100.0% |
| Q3 2019 | $918,000 | -24.3% | 93,478 | -22.6% | 0.00% | -50.0% |
| Q1 2019 | $1,212,000 | -36.1% | 120,750 | +20.8% | 0.00% | 0.0% |
| Q2 2018 | $1,898,000 | – | 100,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|